套住了 止损查看全文
牛唐2020-06-19 14:01
生物医药领域成为疫情期间IPO的亮点,在过去两个月里,包括$Lyra Therapeutics(LYRA)$ 在内,有4家上市公司都属于生物医药的范畴,包括$ORIC制药(ORIC)$ ,$Keros(KROS)$ ,以及Zentalis Pharmaceuticals。这些生物医药公司不仅顺利IPO,而且平均回报率达82%查看全文
$Lyra Therapeutics(LYRA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-23-031867 Size: 5 KB 网页链接
$Lyra Therapeutics(LYRA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-23-031866 Size: 5 KB 网页链接
$Lyra Therapeutics(LYRA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-23-031863 Size: 5 KB 网页链接
$Lyra Therapeutics(LYRA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-23-031869 Size: 5 KB 网页链接
$Lyra Therapeutics(LYRA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-23-031872 Size: 5 KB 网页链接
$Lyra Therapeutics(LYRA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-23-031873 Size: 5 KB 网页链接
$Lyra Therapeutics(LYRA)$ S-3 Registration statement under Securities Act of 1933 Accession Number: 0001193125-23-177495 Act: 33 Size: 367 KB 网页链接
$Lyra Therapeutics(LYRA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-23-029918 Size: 5 KB 网页链接
$Lyra Therapeutics(LYRA)$ 8-K Current report, item 5.07 Accession Number: 0000950170-23-028281 Act: 34 Size: 186 KB 网页链接
$Lyra Therapeutics(LYRA)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-23-070449 Act: 34 Size: 133 KB 网页链接